<DOC>
	<DOCNO>NCT01718873</DOCNO>
	<brief_summary>The purpose study evaluate give bevacizumab prior chemotherapy compare give bevacizumab time chemotherapy improve patient overall response treatment .</brief_summary>
	<brief_title>Optimization Bevacizumab Scheduling With Chemotherapy Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>Histological diagnosis colorectal adenoma carcinoma Stage IV disease Presence least one measurable target lesion ( accord RECIST ) , previously radiate . Age ≥ 18 e ≤ 75 year ECOG Performance status 01 Life expectancy &gt; 3 month Adequate recovery surgery , least 28 day surgery date prestudy biopsy . Adequate contraception male female patient child bear potential informed consent More one previous line therapy metastatic disease Prior treatment bevacizumab oxaliplatin ( previous treatment irinotecan , , cetuximab , fluoropyrimidine , folic acid permit ) Primary tumor stenosing and/or infiltrates entire thickness intestinal wall Regular use NSAIDs aspirin Bleeding disorder coagulopathy Concurrent anticoagulant therapy Suspected cerebral metastasis ( verify presence symptom ) Neutrophils &lt; 2000 / mm3 , platelet &lt; 100,000 / mm3 , hemoglobin &lt; 9g/dl Creatinine &gt; 1.5 time upper normal limit GOT and/or GPT &gt; 2.5 time upper normal limit , bilirubin &gt; 1.5 time upper normal limit absence liver metastasis GOT and/or GPT &gt; 5 time upper normal limit , bilirubin &gt; 3 time upper normal limit presence liver metastases Other coexist malignancy malignancy diagnose within last 5 year exception basal squamous cell carcinoma cervical cancer situ Congestive heart failure , ischemic coronary event within past 12 month , uncontrolled cardiac arrhythmia Uncontrolled hypertension Active uncontrolled infection Any concomitant condition , investigator 's opinion , would contraindicate use study drug Pregnancy lactation Central nervous system disorder peripheral neuropathy &gt; grade 1 ( CTCAE v. 4.0 ) Inability comply follow procedure study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>metastatic</keyword>
	<keyword>stage IV</keyword>
</DOC>